Global Preimplantation Genetic Testing Market, Forecast Till 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 731193
  • |
  • Date : 14-Jan-19
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Preimplantation Genetic Testing Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025 Increasing awareness about preimplantation genetic testing among people suffering from genetic disorders is expected to drive demand for preimplantation genetic testing procedures.

The growth of this market is majorly driven by the rising rate of infertility across the globe, increasing number of fertility clinics worldwide, public-private investments in the field of preimplantation genetic testing, technological advancements in the field of genetic analysis, and the high risk of chromosomal abnormalities in the fetus with increasing maternal age.

Factors, such the high costs incurred in the PGD technologies hamper the growth of the market.
Growth initiatives by key market players and growing medical tourism in the forecast period will offer lucrative opportunities in the market.

Based on procedure type the market is segmented into Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis. The genetic screening segment accounted for the largest share due to continuous decline in female fertility (due to rising maternal age) and benefits offered by PGS, such as increased chances of healthy pregnancy across all age groups.

Based on end user, the Preimplantation Genetic Testing market is segmented into Maternity Centers & Fertility Clinics, Hospitals, Diagnostic Labs, and Service Providers.

Regionally, North America accounted for the largest share of the global preimplantation genetic testing market in 2016, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures.

Some of the key players operating in this market include Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), CooperSurgical, Inc. (U.S.), and Beijing Genomics Institute (BGI) (China)

Key Benefits of the Report:
* Global, Regional, Country, Procedure type, and End-User of Molecule Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Procedure type & End-user of molecule, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Preimplantation Genetic Testing providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity End-user of molecule, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Equipment Manufacturer,
* Procedure type Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 METHODOLOGY AND MARKET SCOPE
2.1 Research Methodology
2.2 Research Scope & Assumptions

3 PREIMPLANTATION GENETIC TESTING MARKET — INDUSTRY OUTLOOK
3.1 Market Segmentation and Scope
3.2 Market Size & Growth Prospects
3.3 Preimplantation Genetic Testing Market — Value Chain / Supply Chain Analysis
3.3.1 Company Landscape
3.4 Preimplantation Genetic Testing Market — Market Dynamics
3.4.1 Market Driver
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Preimplantation Genetic Testing Market Company Market Share, 2017
3.6 Preimplantation Genetic Testing Market — Porter\'s Five Forces Analysis
3.7 Preimplantation Genetic Testing Market — Pestel Analysis

4 PREIMPLANTATION GENETIC TESTING MARKET PROCEDURE TYPE OUTLOOK
4.1 Preimplantation Genetic Testing Market Share by Procedure type, 2016 & 2025
4.2 Preimplantation Genetic Screening
4.3 Preimplantation Genetic Diagnosis

5 PREIMPLANTATION GENETIC TESTING MARKET END-USER OF MOLECULE OUTLOOK
5.1 Preimplantation Genetic Testing Market Share by End-user of molecule, 2016 & 2025
5.2 Laboratories Maternity Centers
5.3 Hospitals
5.4 Diagnostic Labs
5.5 Service Providers
5.6 Fertility Clinics

6 PREIMPLANTATION GENETIC TESTING MARKET REGIONAL OUTLOOK
6.1 Preimplantation Genetic Testing Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America Preimplantation Genetic Testing Market, 2014 - 2025
6.2.2 North America Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.2.3 North America Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.2.5 U.S.
6.2.5.1 U.S. Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.2.5.2 U.S. Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.2.6 Canada
6.2.6.1 Canada Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.2.6.2 Canada Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.3 Europe
6.3.1 Europe Preimplantation Genetic Testing Market, 2014 - 2025
6.3.2 Europe Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.3.3 Europe Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.3.5 Germany
6.3.5.1 Germany Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.3.5.2 Germany Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.3.6 UK
6.3.6.1 UK Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.3.6.2 UK Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific Preimplantation Genetic Testing Market, 2014 - 2025
6.4.2 Asia Pacific Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.4.3 Asia Pacific Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.4.5 Australia
6.4.5.1 Australia Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.4.5.2 Australia Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.4.6 New Zealand
6.4.6.1 New Zealand Preimplantation Genetic Testing Market, By Procedure type, 2014 -
2025
6.4.6.2 New Zealand Preimplantation Genetic Testing Market, By End-user of molecule, 2014 -2025
6.4.7 China
6.4.7.1 China Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.4.7.2 China Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.4.8 India
6.4.8.1 India Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.4.8.2 India Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.4.9 Japan
6.4.9.1 Japan Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.4.9.2 Japan Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.5 South America
6.5.1 South America Preimplantation Genetic Testing Market, 2014 - 2025
6.5.2 South America Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.5.3 South America Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.5.5 Brazil
6.5.5.1 Brazil Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.5.5.2 Brazil Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.5.6 Mexico
6.5.6.1 Mexico Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.5.6.2 Mexico Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025
6.6 MEA
6.6.1 MEA Preimplantation Genetic Testing Market, 2014 - 2025
6.6.2 MEA Preimplantation Genetic Testing Market, By Procedure type, 2014 - 2025
6.6.3 MEA Preimplantation Genetic Testing Market, By End-user of molecule, 2014 - 2025

7 COMPETITIVE LANDSCAPE
7.1 F. Illumina, Inc.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Procedure type benchmarking
7.1.4 Strategic initiatives
7.2 Thermo Fisher Scientific Inc
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Procedure type benchmarking
7.2.4 Strategic initiatives
7.3 Agilent Technologies, Inc.
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Procedure type benchmarking
7.3.4 Strategic initiatives
7.4 PerkinElmer, Inc
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Procedure type benchmarking
7.4.4 Strategic initiatives
7.5 CooperSurgical, Inc.
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Procedure type benchmarking
7.5.4 Strategic initiatives

End of the report
Disclaimer

Content are not available

Choose License Type